Show simple item record

dc.contributor.authorAldalwg, M.
dc.contributor.authorBrestovac, Brian
dc.identifier.citationAldalwg, M. and Brestovac, B. 2017. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective. Head and Neck Pathology. 11 (3): pp. 377-384.

© 2017, Springer Science+Business Media New York. Human papillomavirus (HPV) associated head and neck squamous cell carcinomas (HNSCCs), have become a serious global health problem. Despite decreases in HPV-negative HNSCCs, the prevalence of HPV-positive HNSCCs has significantly increased. HPV-positive cancers are associated with superior survival outcomes when compared to HPV-negative cancers, which appears likely to be associated with differences in the molecular pathogenesis of the two diseases. While therapies are still problematic, the current HPV vaccine programs hold a promise for the primary prevention of HPV-related HNSCCs and since Australia was the first to introduce a nationwide HPV vaccine program, it is in a unique position to observe the effects of the vaccine on HNSCCs. This review discusses the epidemiological trends associated with HPV in HNSCC, with reference to the differences between HPV-positive and HPV-negative HNSCCs and the prevention potential of HPV vaccines.

dc.titleHuman Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective
dc.typeJournal Article
dcterms.source.titleHead and Neck Pathology
curtin.departmentSchool of Biomedical Sciences
curtin.accessStatusFulltext not available

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record